date:Dec 06, 2013
ve VP Cultures Enzymes and Member of the Executive Board said: During the last 3-5 years, we havent increased the prices on our coagulants, but we have now come to the conclusion that this is no longer sustainable, as the input costs for raw materials, energy and other indirect costs have gone up.
At the same time our customers expect that we continue to invest in innovation. In order to do that we needed to do something to protect our margins with these cost increases. We have a normal cost i